AGC Biologics Announces Change in Executive Leadership
BOTHELL, Washington, Jan. 7, 2019 /PRNewswire-AsiaNet/ -- -- Mark Womack to Succeed Robert Broeze, PhD as Chief Business Officer of AGC BiologicsAGC Biologics today announces a change in executive leadership, appointed by their board of directors. Robert (Bob) Broeze will retire on March 5th, 2019 af...
Read more https://view-release/?pr-id=76955